DF / resected pancreatic cancer / residual disease / pancreatic head cancer / occult metastatic disease / metastasis / local disease / primary pancreatic cancer / nausea / J Cancer / distant metastasis / locoregional disease / severe infection / pancreatic disease / metastasized pancreatic cancer / either locally advanced disease / resectable pancreatic cancer / Pancreatic cancer / adenocarcinoma / pancreatic adenocarcinoma / abdominal pain / biliary tract cancer / Cancer / distant disease / disease / tumour / disseminated disease / distant metastatic disease / vomiting / metastatic pancreatic cancer / resected pancreatic adenocarcinoma / hilar cholangiocarcinoma / hepatobiliary and pancreatic cancer / isolated recurrent pancreatic cancer / tumours / /
MedicalTreatment
radiation therapy / adjuvant chemotherapy / cancer surgery / chemotherapy / radiotherapy / surgery / radiation / Adjuvant radiotherapy / adjuvant therapy / /
OperatingSystem
Microsoft Windows / /
Organization
University of Heidelberg / Universität München / World Health Organization / Winchester DP / Johns Hopkins University / U.S. Securities and Exchange Commission / University Hospital of Heidelberg / Department of Radiation Oncology / MWB / Johns Hopkins Hospital / 6National Center for Tumor Diseases / JD / DJ / CS / International Agency for Research / /
Person
Van Tienhoven / Ann Surg / Median / Arch Surg / Kerstin Kessel / Van Laethem / Ann Surg Oncol / /
Position
treating surgeon / range Head / abdominal RT / fractionated RT / RT / author / postoperative RT / adjuvant RT / pathologist / pancreatic head / /
Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma